Clarity Pro R&D Bioinstrumentation from IRSI

International Research Services, Inc. (IRSI) (Booth No. 130), s a leader in biophysical instrumental analyses and visual and tactile dermatological assessment, offering quality performance of safety andin-use trials. The reliable results from each of these trial types performed at IRSI may be used to make strategic marketing determinations and to substantiate marketing claims for a vast array of pharmaceuticals and Over-The-Counter treatments, cosmetics, “cosmeceutical” and “nutraceutical” products, and other product types which may come into contact with human skin.

IRSI’s new Clarity Pro R&D bioinstrumentation – captures full face images in multi-spectral lighting : True White Light and Deep Blue Light images to reveal skin conditions on and beneath the skin’s surface layer. Intelligently distinguishes predominant facial features and maps out the skin within each captured image. An automated, internal alignment procedure provides an intuitive guide for capturing consistent and reproducible images. Developed in synergy with global leaders in the skin care industry for use in clinical trials and product efficacy testing, Clarity Pro R&D is a comprehensive system that delivers an un-paralleled level of measurement capability with quantification of more than 25 skin parameters.

More info: IRSI, 914.937.6500; Email: [email protected]; Website: www.irsi.org